Alisi A
Alisi A
Bambino Gesù Children's Hospital and Research Institute
Verified email at
Cited by
Cited by
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
F Del Chierico, V Nobili, P Vernocchi, A Russo, C De Stefanis, D Gnani, ...
Hepatology 65 (2), 451-464, 2017
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non‐alcoholic steatohepatitis
A Alisi, G Bedogni, G Baviera, V Giorgio, E Porro, C Paris, P Giammaria, ...
Alimentary pharmacology & therapeutics 39 (11), 1276-1285, 2014
I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
L Valenti, A Alisi, E Galmozzi, A Bartuli, B Del Menico, A Alterio, ...
Hepatology 52 (4), 1274-1280, 2010
Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
V Nobili, G Bedogni, A Alisi, A Pietrobattista, P Risé, C Galli, C Agostoni
Archives of disease in childhood 96 (4), 350-353, 2011
Complications, morbidity and mortality of nonalcoholic fatty liver disease
A Mantovani, E Scorletti, A Mosca, A Alisi, CD Byrne, G Targher
Metabolism 111, 154170, 2020
Antioxidant effects of natural bioactive compounds
C Balsano, A Alisi
Current pharmaceutical design 15 (26), 3063-3073, 2009
Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review.
V Nobili, A Alisi, N Panera, C Agostoni
Pediatric endocrinology reviews: PER 6 (2), 241-247, 2008
Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease
A Alisi, L Da Sacco, G Bruscalupi, F Piemonte, N Panera, R De Vito, ...
Laboratory investigation 91 (2), 283-293, 2011
A 360-degree overview of paediatric NAFLD: recent insights
V Nobili, G Svegliati-Baroni, A Alisi, L Miele, L Valenti, P Vajro
Journal of hepatology 58 (6), 1218-1229, 2013
Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children
V Nobili, A Alisi, C Della Corte, P Risé, C Galli, C Agostoni, G Bedogni
Nutrition, Metabolism and Cardiovascular Diseases 23 (11), 1066-1070, 2013
NAFLD in children: new genes, new diagnostic modalities and new drugs
V Nobili, A Alisi, L Valenti, L Miele, AE Feldstein, N Alkhouri
Nature reviews Gastroenterology & hepatology 16 (9), 517-530, 2019
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
V Giorgio, L Miele, L Principessa, F Ferretti, MP Villa, V Negro, A Grieco, ...
Digestive and Liver Disease 46 (6), 556-560, 2014
Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cells via microRNA targeting peroxisome proliferator-activated receptor-γ
D Povero, N Panera, A Eguchi, CD Johnson, BG Papouchado, ...
Cellular and molecular gastroenterology and hepatology 1 (6), 646-663. e4, 2015
Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease
V Nobili, G Carpino, A Alisi, A Franchitto, G Alpini, R De Vito, P Onori, ...
Hepatology 56 (6), 2142-2153, 2012
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study
V Nobili, M Manco, P Ciampalini, A Alisi, R Devito, E Bugianesi, ...
Clinical therapeutics 30 (6), 1168-1176, 2008
The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
V Nobili, A Alisi, A Vania, C Tiribelli, A Pietrobattista, G Bedogni
BMC medicine 7, 1-7, 2009
Pediatric nonalcoholic fatty liver disease in 2009
A Alisi, M Manco, A Vania, V Nobili
The Journal of pediatrics 155 (4), 469-474, 2009
Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children
A Alisi, M Manco, R Devito, F Piemonte, V Nobili
Journal of pediatric gastroenterology and nutrition 50 (6), 645-649, 2010
Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents
A Mosca, V Nobili, R De Vito, A Crudele, E Scorletti, A Villani, A Alisi, ...
Journal of hepatology 66 (5), 1031-1036, 2017
The system can't perform the operation now. Try again later.
Articles 1–20